Although JRI is a traditional manufacturing company, we have a long standing history innovation and are actively involved in the co-development of disruptive technologies which is supported by our own multidisciplinary team in Technology Research. The aim of Technology Research is to improve the lives of our patients through the development of new technologies for the advanced treatment of joint disease leading to improved treatments. We co-develop novel materials, advanced manufacturing processes, new treatment approaches and regenerative medical products with leading clinical and non-clinical academics as well as other commercial collaborators from around UK and Europe. We ensure our research activity is commercially sustainable through grant funding, future revenue arising from protected intellectual property and future direct sales from advanced products. This Technology Research arm of JRI is called Otheia and more information can be found at their web-site, ortheia.com
Working on early stage regenerative remediation of hip osteoarthritis by novel curvilinear arthroscopy.
Novel 3D coating of bioactive glass and metal composites.
Femtosecond-pulsed-laser Augment/bioglass Sintering Technique for Implant Customisation.
Resorbable ceramic biocomposites for orthopaedic and maxillofacial applications.
- Implant Direct
The direct manufacturing of personalised implants using selected laser melting.